Abstract | AIMS: Immunohistochemical prognostic factors of pulmonary metastatic colorectal cancer lesions have not been well investigated. The study was conducted to identify the immunohistochemical prognostic factors of metastasized colorectal cancer. METHODS: We immunohistochemically investigated the expression of insulin-like growth factor-1 receptor (IGF1-R), E-cadherin, beta-catenin, and p53 using a tissue microarray in the surgical specimens of 86 metastatic lesions. RESULTS: The univariate analysis revealed E-cadherin and membrane beta-catenin positive to be prognostic factors. IGF1-R and p53 were not significantly associated with the patient's survival. In multivariate analysis, the reduced expression of E-cadherin, aerogenous spread with floating cancer cell clusters and vascular invasion were independent prognostic factors. CONCLUSIONS: The reduced expression of E-cadherin in the pulmonary metastatic lesions was an independent predictor of poor survival after pulmonary metastasectomy.
|
Authors | S Shiono, G Ishii, K Nagai, Y Murata, K Tsuta, J Nitadori, T Kodama, A Ochiai |
Journal | European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology
(Eur J Surg Oncol)
Vol. 32
Issue 3
Pg. 308-9
(Apr 2006)
ISSN: 0748-7983 [Print] England |
PMID | 16459049
(Publication Type: Comparative Study, Journal Article)
|
Chemical References |
- Biomarkers, Tumor
- Cadherins
- Tumor Suppressor Protein p53
- beta Catenin
- Receptor, IGF Type 1
|
Topics |
- Biomarkers, Tumor
(metabolism)
- Cadherins
(metabolism)
- Carcinoma
(metabolism, secondary, surgery)
- Colorectal Neoplasms
(metabolism, pathology)
- Humans
- Immunohistochemistry
- Lung Neoplasms
(metabolism, secondary, surgery)
- Pneumonectomy
- Prognosis
- Receptor, IGF Type 1
(metabolism)
- Retrospective Studies
- Tumor Suppressor Protein p53
(metabolism)
- beta Catenin
(metabolism)
|